A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus (BRAVE I) January 21, 2019https://clinicaltrials.gov/ct2/show/NCT03616912 A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus (BRAVE I)
